Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Post by edroseon Nov 16, 2021 8:03am
90 Views
Post# 34130652

since takeover look at salaries they have been paying

since takeover look at salaries they have been payingthemselves for what     selling assets  like isle of man for 50 million.selling plasma division that had great potential ie ivig  ryplasim   they put hold on research re small molecules  like 4050  

unfortunetly not much left in the company  except money they got for voucher   and they will pay themselves back ie loan from salp which is co based in cayman island owned by thomvest


<< Previous
Bullboard Posts
Next >>